Infection by gram-negative organisms via the biliary route results in greater mortality than portal venous infection

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 4, 2003, Pages 664-669

  Jeyarajah, D Rohan ^a,b   Kielar, Mariusz L ^a   Frantz, Nicole ^a   Lindberg, Guy ^a   Lu, Christopher Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b FACS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT OBSTRUCTION; CHOLANGITIS; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; HEPATOBILIARY SYSTEM; LETHAL DOSE; LIVER; MALE; MORTALITY; MOUSE; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; CHOLANGITIS; CHOLESTASIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HEPATITIS; INJECTIONS, INTRAVENOUS; INTERLEUKINS; LIGATION; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; PORTAL VEIN; RNA, MESSENGER;

EID: 0037767848     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.4.664-669.2003     Document Type: Article

References (29)

1. Ayala, A., J. B. Knotts, W. Ertel, M. M. Perrin, M. H. Morrison, and I. H. Chaudry. 1993. Role of interleukin 6 and transforming growth factor-beta in the induction of depressed splenocyte responses following sepsis. Arch. Surg. 128:89-94.
2. Diamond, T., S. Dolan, R. L. Thompson, and B. J. Rowlands. 1990. Development and reversal of endotoxemia and endotoxin-related death in obstructive jaundice. Surgery 108:370-374.
3. Frangogiannis, N. G., L. H. Mendoza, M. L. Lindsey, C. M. Ballantyne, L. H. Michael, C. W. Smith, and M. L. Entman. 2000. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J. Immunol. 165:2798-2808.
4. Hanau, L. H., and N. H. Steigbigel. 2000. Acute (ascending) cholangitis. Infect. Dis. Clin, N. Am. 14:521-546.
5. Hess, P. J., J. M. Seeger, T. S. Huber, M. B. Welborn, T. D. Martin, T. R. Harward, S. Duschek, P. D. Edwards, C. C. Solorzano, E. M. Copeland, et al; 1997. Exogenously administered interleukin-10 decreases pulmonary neutrophil infiltration in a tumor necrosis factor-dependent murine model of acute visceral ischemia. J. Vasc, Surg. 26:113-118.
6. Huber, T. S., G. C. Gaines, M. B. Welborn, J. J. Rosenberg, J. M. Seeger, and L. L. Moldawer. 2000, Anticytokine therapies for acute inflammation and the systemic inflammatory response syndrome: IL-10 and ischemia/reperfusion injury as a new paradigm. Shock 13:425-434.
7. Jeyarajah, D. R., and R. V. Rege. 2001. Biliary infection: cholecystitis and cholangitis, p. 157-159. In D. Schlossberg, R. Zorab, and J. Shreiner (ed.), Current therapy of infectious disease. The C.V. Mosby Co., St. Louis, Mo.
8. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141-1147.
9. Kennedy, J. A., H. Lewis, W. D. B. Clemens, S. J. Kirk, G. Campbell, M. I. Halliday, and B. J. Rowlands. 1999. Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br. J. Surg. 86:1410-1414.
10. Kennedy, J. A., W. D. Clements, S. J. Kirk, M. D. McCaigue, G. R. Campbell, P. J. Erwin, M. I. Halliday, and B. J. Rowlands. 1999. Characterization of the Kupffer cell response to exogenous endotoxin in a rodent model of obstructive jaundice. Br. J. Surg. 86:628-633.
11. Knolle, P. A., and G. Gerken. 2000. Local control of the immune response in the liver. Immunol. Rev. 174:21-34.
12. Lentsch, A. B., H. Yoshidome, W. G. Cheadle, F. N. Miller, and M. J. Edwards. 1998. Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC. Hepatology 27:1172-1177.
13. Lim, B. K., S. C. Choe, J. O. Shin, S. H. Ho, J. M. Kim, S. S. Yu, S. Kim, and E. S. Jeon. 2002. Local expression of interleukin-1 receptor antagonist by plasmid DNA improves mortality and decreases myocardial inflammation in experimental coxsackieviral myocarditis. Circulation 105:1278-1281.
14. Loffreda, S., R. Rai, S. Q. Yang, H. Z. Lin, and A. M. Diehl. 1997. Bile ducts and portal and central veins are major producers of tumor necrosis factor alpha in regenerating rat liver. Gastroenterology 112:2089-2098.
15. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991-1045.
16. Minagawa, M., H. Oya, S. Yamamoto, T. Shimizu, M. Bannai, H. Kawamura, K. Hatakeyama, and T. Abo. 2000. Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology 31:907-915.
17. Olszyna, D. P., D. Pajkrt, F. N. Lauw, S. J. H. van Deventer, and T. van der Poll. 2000. Interleukin 10 inhibits the release of CC chemokines during human endotoxemia. J. Infect. Dis. 181:613-620.
18. Patel, R. T., K. I. Deen, D. Youngs, J. Warwick, and M. R. Keighley. 1994. Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis. Br. J. Surg. 81:1306-1308.
19. Plebani, M., M. P. Panozzo, D. Basso, M. De Paoli, R. Biasin, and D. Infantolino. 1999. Cytokines and the progression of liver damage in experimental bile duct ligation. Clin. Exp. Pharmacol. Physiol. 26:358-363.
20. Song, G. Y., C. S. Chung, I. H. Chaudry, and A. Ayala. 1999. What is the role of interleukin 10 in polymicrobial sepsis: anti-inflammatory agent or immunosuppressant? Surgery 126:378-383.
21. Sud, S., S. Y. Yang, C. H. Evans, P. D. Robbins, and P. H. Wooley. 2001. Effects of cytokine gene therapy on particulate-induced inflammation in the murine air pouch. Inflammation 25:361-372.
22. Tanaka, N., P. Christensen, S. Ryden, B. Klofver-Stahl, and S. Bengmark. 1985. Biliary obstruction and susceptibility to biliary sepsis in rats. Res. Exp. Med. (Berlin) 185:115-119.
23. Tomioka, M., H. Iinuma, and K. Okinaga. 2000. Impaired Kupffer cell function and effect of immunotherapy in obstructive jaundice. J. Surg. Res. 92:276-282.
24. van der Poll, T., P. M. Jansen, W. J. Montegut, C. C. Braxton, S. E. Calvano, S. A. Stackpole, S. R. Smith, S. W. Swanson, C. E. Hack, S. F. Lowry, and L. L. Moldawer. 1997. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia. J. Immunol. 158:1971-1975.
25. Van Laethem, J. L., R. Eskinazi, H. Louis, F. Rickaert, R. Robberecht, and J. Deviere. 1998. Multisystemic production of interleukin 10 limits the severity of acute pancreatitis in mice. Gut 43:408-413.
26. Volk, H. D., K. Asadullah, G. Gallagher, R. Sabat, and G. Grutz. 2001. IL-10 and its homologs: important immune mediators and emerging immunotherapeutic agents. Trends Immunol. 22:414-417.
27. Wang, M., K. C. Jeng, and L. I. Ping. 1999. Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide-hyporesponsive C3H/HeJ mice with Klebsiella infection. Immunology 98:90-97.
28. Yang, Z., B. Zingarelli, and C. Szabo. 2000. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 101:1019-1026.
29. Zwacka, R. M., Y. Zhang, J. Halldorson, H. Schlossberg, L. Dudus, and J. F. Engelhardt. 1997. CD4+ T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver. J. Clin. Investig. 100:279-289.